Oral contraceptive use in relation to smoking

Acta Obstetricia et Gynecologica Scandinavica

Volumn 77, Issue 2, 1998, Pages 205-209

  Morabia, Alfredo ^a,b   Bernstein, Martine ^a   Bleed, Daniel ^a   Campana, Aldo ^a  

^a University Hospital   (Switzerland)

^b UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Epidemiology; Guidelines; Myocardial infarction; Oral contraceptives; Survey; Tobacco smoking; Venous thromboembolism

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGE; ARTICLE; FEMALE; HEART INFARCTION; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SWITZERLAND; VEIN THROMBOSIS;

EID: 0031884065     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1080/j.1600-0412.1998.770215.x     Document Type: Article

References (17)

1. Brezinka V, Padmos I. Coronary heart disease risk factors in women. Eur Heart J 1994; 15: 1571-84.
2. Knopp RH, LA Rosa JC, Burkman RT. Contraception and dyslipidemia. Am J Obstet Gynecol 1993; 168: 1994-2005.
3. Anonymous. Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study. Lancet 1981; 1: 541-6.
4. Rosenberg L, Kaufman DW, Helmrich SP, Miller DR, Stolley PD, Shapiro S. Myocardial infarction and cigarette smoking in women younger than 50 years of age. JAMA 1985; 253; 2965-9.
5. Lewis MA, Spitzer WO, Heinemann LA, MacRae KD, Bruppacher R, Thorogood M. Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ 1996; 312: 88-90.
6. Sharpe CR. Smoking among oral contraceptive users in Quebec in 1987. J Clin Epidemiol 1994; 47: 313-23.
7. Lidegaard O, Helm P. Sexual and reproductive life events in relation to duration of oral contraceptive use. Contraception 1988; 38: 69-77.
8. Morabia A, Khatchatrian N, Bernstein M, Walker DM, Campana A. Reproductive characteristics of a population of urban Swiss women. Acta Obstet Gynecol Scand 1996; 75: 838-42.
9. Riphagen FE, Lehert P. A survey of contraception in five West European countries. J Biosoc Sci 1989; 21: 23-46.
10. Oddens BJ, Visser AP, Vemer HM, Everaerd WT, Lehert P. Contraceptive use and attitudes in Great Britain. Contraception 1994; 49: 73-86.
11. Morabia A, Bernstein M, Heritier S, Khatchatrian N. Relationship of breast cancer with passive and active exposure to tobacco smoke. Am J Epidemiol 1996; 143: 918-28.
12. Pill scare linked to rise in abortions. BMJ 1996; 312: 996.
13. 'Women warned about 7 brands of contraceptives'. Guardian, October 20, 1995.
14. Anomymous. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 1995; 346:1575-82.
15. Anonymous. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 1995; 346: 1582-8.
16. Spitzer WO, Lewis MA, Heinemann LA, Thorogood M, MacRae KD. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. BMJ 1996; 312: 83-8.
17. Farmer RDT, Lawrenson RA, Kennedy JG, Hambleton IR. Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet 1997; 349: 83-8.